KPIs & Operating Metrics(New)
Adjusted Operating Income By Segment AnnualAdjusted Operating Margin By Segment Annual %BacklogBacklog AnnualBreakdown Of AssetsBusiness Unit Revenue Drug DevelopmentCapital ExpenditureContractual Obligations TotalCost Of RevenuesDepreciation And Amortization By SegmentEmployeeGoodwill By SegmentGross Margin %Gross ProfitIncome Before Income Taxes By RegionNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Income By SegmentOperating Margin By Segment %Opex As A % Of Total Revenue %OPEX SegregationProperty, Plant And Equipment, Net BreakdownProperty, Plant And Equipment, Net By GeographyProperty, Plant And Equipment, Net By SegmentQuarterly Net Order Drug DevelopmentRemaining Performance ObligationsRemaining Performance Obligations AnnualRevenue By Base Business Diagnostics RevenueRevenue By Business VerticalRevenue By Business Vertical %Revenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By PayerRevenue By Payer %Revenue By Payer AnnualRevenue By Payer Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Revenue Mix Base Business Diagnostics Revenue %Revenue Per Employee %Revenuue Mix By Geography %Unearned Revenue
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Labcorp Holdings (LH) Gross Profit (2016 - 2025)

Labcorp Holdings (LH) has disclosed Gross Profit for 17 consecutive years, with $993.2 million as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 10.81% to $993.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 billion through Dec 2025, up 10.71% year-over-year, with the annual reading at $4.0 billion for FY2025, 10.71% up from the prior year.
  • Gross Profit hit $993.2 million in Q4 2025 for Labcorp Holdings, down from $1.0 billion in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $1.6 billion in Q1 2021 to a low of $743.1 million in Q4 2021.
  • Historically, Gross Profit has averaged $992.7 million across 5 years, with a median of $915.4 million in 2024.
  • Biggest YoY gain for Gross Profit was 119.64% in 2021; the steepest drop was 60.99% in 2021.
  • Year by year, Gross Profit stood at $743.1 million in 2021, then rose by 7.4% to $798.1 million in 2022, then grew by 2.92% to $821.4 million in 2023, then rose by 9.12% to $896.3 million in 2024, then grew by 10.81% to $993.2 million in 2025.
  • Business Quant data shows Gross Profit for LH at $993.2 million in Q4 2025, $1.0 billion in Q3 2025, and $1.0 billion in Q2 2025.